Andrei V. Gudkov and Mikhail Blagosklonny are the dynamic duo behind the scenes of Oncotarget’s abundance of success. The two chief editors have worked long and hard to build the open access medical journal into the powerhouse it is today. When you look at where Oncotarget is today and think to yourself that Gudkov and Blagosklonny played such a major role in its development, it’s then hard to imagine two professionals more suited for the job.
The two are sincerely passionate about the topics and both work at Roswell Park Institute. Their teamwork is impeccable, constantly bouncing ideas off each other. They’re constantly brainstorming and coming up with ways to give Oncotarget a bigger global audience. With these two at the helm, Oncotarget has been named the number one ranked journal in oncology by Thomson Reuters JCR Impact Factor. Visit his profile on Google Scholar.
In Oncotarget’s upstart phase, the journal only published papers from authors covering research on oncology. Realizing that the journal was growing at a rapid pace the duo decided to diversify and launch sections beyond oncology including: cardiology, microbiology, pharmacology and neuroscience.
Oncotarget Study on E-Cigarettes
Recently Oncotarget released its first published study on the dangers of e-cigarettes earlier this year. The study focused on the connection between e-cigarette users and gum soreness and inflammation. The oral damage actually mimics that of a traditional tobacco cigarette because of the negative effect they have on the periodontal cells. Because of the findings in the study Oncotarget discourage any exposure to the metal heating elements as they pose more threat to the human body. Download output styles at Endnote.com